Androgen Deprivation Therapy for Prostate Cancer Does Not Increase Cardiovascular Mortality in the Long Term

Publisher： Karger

E-ISSN： 1423-0232|82|1|56-58

ISSN： 0030-2414

Source： Oncology, Vol.82, Iss.1, 2012-02, pp. : 56-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 358-365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external‐beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3260-3261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3265-3271

John Wiley & Sons Inc

Access to resources Recommend Favorite

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite